Worth Venture Partners’s OptiNose OPTN Stock Holding History

Worth Venture Partners’s Portfolio OPTN Stock Details OPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-6,591	Closed	-$444K	–	134
2020 Q1	$444K	Buy	+6,591	New	+$664K	0.27%	55

Other funds holding OPTN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Worth Venture Partners's OPTN Position: Q2 2020 in Review

Worth Venture Partners sold out of OptiNose (OPTN) in Q2 2020, closing a stake of 6,591 shares — an estimated $444K sold.

Worth Venture Partners first reported a position in OPTN in Q1 2020 and held it in 1 quarter. The position peaked at $444K in Q1 2020. 72 funds tracked by Wall St. Rank hold OPTN as of Q2 2020.

Worth Venture Partners reported no remaining OptiNose position as of Q2 2020 after selling out during the quarter.
Worth Venture Partners sold 6,591 OptiNose shares in Q2 2020, an estimated $444K.
Worth Venture Partners first reported a position in OptiNose in Q1 2020 and held it in 1 quarter.
Worth Venture Partners's OptiNose position peaked at $444K in Q1 2020.
72 funds tracked by Wall St. Rank held OptiNose as of Q2 2020.

Based on Worth Venture Partners's 13F filing for Q2 2020, filed 14 Aug 2020.